Long-Term Effects of Golimumab in Patients with Arthritis
Clinicians are generally familiar with the side effects of most prescribed medications. However, the safety of newer medications such as golimumab, an anti-TNF drug to treat autoimmune disorders, is still being examined.
FDA Approves Two Meds for New Use
New options developed this week for patients coping with two very different arthritic conditions. T he US Food and Drug Administration (FDA) has approved two medications for treatment of both rheumatoid arthritis and ankylosing spondylitis.